Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Clayton, Matthew J. | - |
dc.contributor.author | Hartzel, Jay C. | - |
dc.contributor.author | Rosenberg, Joshua | - |
dc.date.accessioned | 2008-05-27T12:48:41Z | - |
dc.date.available | 2008-05-27T12:48:41Z | - |
dc.date.issued | 2000-08 | - |
dc.identifier.uri | http://hdl.handle.net/2451/26625 | - |
dc.description.abstract | A change in executive leadership is a significant event in the life of a firm. Our paper investigates a potentially significant consequence of a CEO turnover: a change in equity volatility. We develop several hypotheses about how CEO changes might affect stock price volatility, and test these hypotheses using a sample of 872 CEO changes over the 1979-1995 period. We find that volatility increases following a CEO turnover, even for the most frequent type, when a CEO leaves voluntarily and is replaced by someone from inside the firm. Our results indicate that forced turnovers, which are expected to result in large strategy changes, increase volatility more than voluntary turnovers. Outside successions, which are expected to result in a successor CEO with less certain skill in managing the firm's operations, increase volatility more than inside turnovers. We also document a greater stock-price response to earnings announcements around CEO turnover, consistent with more informative signals of value driving the increased volatility. Controls for firm-specific characteristics indicate that the volatility changes cannot be entirely attributed to factors such as changes in firm operations, firm size, and both volatility change and performance prior to the turnover. | en |
dc.language.iso | en_US | en |
dc.relation.ispartofseries | FIN-00-002 | en |
dc.title | The Impact of CEO Turnover on Equity Volatility | en |
dc.type | Working Paper | en |
Appears in Collections: | Finance Working Papers |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
FIN-00-002.pdf | 172.87 kB | Adobe PDF | View/Open |
Items in FDA are protected by copyright, with all rights reserved, unless otherwise indicated.